ArticleBioMed research international2020

Inhibition of the CDK4/6-Cyclin D-Rb Pathway by Ribociclib Augments Chemotherapy and Immunotherapy in Renal Cell Carcinoma.

Dehong Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.